Articles dans des revues avec comité de lecture (26)
  1. 25. Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J. P. (2007). Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. The American journal of pathology, 171(3), 976-992. doi:10.2353/ajpath.2007.070345
  2. 26. Leroy, K., Yilmaz, Z., & Brion, J. P. (2007). Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathology and applied neurobiology, 33(1), 43-55. doi:10.1111/j.1365-2990.2006.00795.x
    3.   Communications publiées lors de congrès ou colloques nationaux et internationaux (7)
  3. 1. Ando, K., Pregoni, G., Verheijen, J., Vergara Panos, C., De Decker, R., Mansour, S., Yilmaz, Z., Suain, V., Dauphinot, L., Fontaine, G., Leroy, K., Duyckaerts, C., Sleegers, K., Potier, M.-C., & Brion, J. P. (2018). PICALM susceptible loci and the levels of its mRNA and protein expression. 2nd EUROtau meeting abstract book 2nd EUROtau meeting(2: 26-27 April 2018: Lille, France)
  4. 2. Houben, S., Audouard, E., Masaracchia, C., Yilmaz, Z., Suain, V., Authelet, M., De Decker, R., Buée, L., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2016). Stereotaxic injection of fibrillar PHF from Alzheimer brain induces propagation of argyrophilic grains constituted of murine tau in mouse brains. Front. Aging Neurosci.. Vol. 40 6th Belgian Brain Congress.(6: 2016-10-08: Mons, Belgium). doi:10.3389/conf.fnagi.2016.03.00040
  5. 3. Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara Panos, C., Belkouch, M., Potier, M.-C., Duyckaerts, C., & Brion, J. P. (2016). Clathrin adaptor CALM/PICALM is involved in tau pathology in Alzheimer and other tauopathies. Front. Aging Neurosci. Vol. 17 6th Belgian Brain Congress.(6: 2016-10-08: Mons). doi:10.3389/conf.fnagi.2016.03.00017
  6. 4. Vergara Panos, C., Houben, S., Vanden Dries, V., Yilmaz, Z., Suain, V., De Decker, R., Duyckaerts, C., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2016). PHF-tau propagation in the presence of Amyloid ß pathology. Front. Aging Neurosci. (p. 219818) 6TH BELGIAN BRAIN CONGRESS(6: 2016-10-08: Mons, Belgium). doi:10.3389/conf.fnagi.2016.03.00017
  7. 5. Brion, J. P., Heraud, C., Leroy, K., Ando, K., Suain, V., Dedecker, R., Authelet, M., Laporte, V., Pierrot, N., Octave, J. N., & Yilmaz, Z. (2013). Wild-type and mutant tau expression affects APP processing. In Alzheimer's & Dementia: The Journal of the Alzheimer's Association: Vol. 9 (4 ed., p. 142) Elsevier.
  8. 6. Leroy, K., Ando, K., Laporte, V., Dedecker, R., Suain, V., Authelet, M., Heraud, C., Pierrot, N., Yilmaz, Z., Octave, J. N., & Brion, J. P. (2012). Tau deletion rescues neuronal death in APP/PS1 mice. In Alzheimer's & Dementia: The journal of the Alzheimer's association: Vol. 8 (4 ed., p. 87) Elsevier.
  9. 7. Brion, J. P., Leroy, K., Ando, K., Bretteville, A., Yilmaz, Z., Authelet, M., Dedecker, R., & Buée, L. (2008). Subacute per OS lithium treatment decreases Tau phosphorylation and neurofibrillary tangles load in G272V/P301S mutant Tau transgenic mice. Alzheimer's & Dementia: The Journal of Alzheimer's Association. Vol. 4 (4 ed., p. 185) ICAD 2008(2008-07-26 to 2008-07-31: Chicago, USA).
    10.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
  10. 1. Ando, K., Ferlini, L., Suain, V., Yilmaz, Z., Mansour, S., Le Ber, I., Bouchard, C., Leroy, K., Durr, A., Clot, F., Sarazin, M., & Bier, J. C. (2020). De novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia. Acta neuropathologica communications, 8(1), 94. doi:10.1186/s40478-020-00977-8
    11.   Participations à des congrès et colloques internationaux (40)
  11. 1. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Mansour, S., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau do not spread tau pathology to the brain via the retinotectal pathway after intraocular injection in mouse models. Paper session presented at International conference on Alzheimer and Parkinson's diseases (15-22 March 2022: Barcelona).
  12. 2. De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2022). Intravenous injection of PHF-Tau proteins from Alzheimer Brain exacerbates neuroinflammation, Amyloid beta, and tau pathologies in 5XFAD transgenic mice.. Vol. 145 (p. 411) Abstract session presented at International conference on Alzheimer and Parkinson's diseases(15-20 Mars 2022: Barcelona).
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>